Exploration of Targeted Anti-tumor Therapy (Aug 2022)

Roles of calcium signaling in cancer metastasis to bone

  • Tianying Xie,
  • Sitong Chen,
  • Jiang Hao,
  • Pengfei Wu,
  • Xuelian Gu,
  • Haifeng Wei,
  • Zhenxi Li,
  • Jianru Xiao

DOI
https://doi.org/10.37349/etat.2022.00094
Journal volume & issue
Vol. 3, no. 4
pp. 445 – 462

Abstract

Read online

Bone metastasis is a frequent complication for cancers and an important reason for the mortality in cancer patients. After surviving in bone, cancer cells can cause severe pain, life-threatening hypercalcemia, pathologic fractures, spinal cord compression, and even death. However, the underlying mechanisms of bone metastasis were not clear. The role of calcium (Ca2+) in cancer cell proliferation, migration, and invasion has been well established. Interestingly, emerging evidence indicates that Ca2+ signaling played a key role in bone metastasis, for it not only promotes cancer progression but also mediates osteoclasts and osteoblasts differentiation. Therefore, Ca2+ signaling has emerged as a novel therapeutical target for cancer bone metastasis treatments. Here, the role of Ca2+ channels and Ca2+-binding proteins including calmodulin and Ca2+-sensing receptor in bone metastasis, and the perspective of anti-cancer bone metastasis therapeutics via targeting the Ca2+ signaling pathway are summarized.

Keywords